FDA alert: Canagliflozin use may be associated with toe, foot amputations

Interim safety results from an ongoing clinical trial found an increase in leg and foot amputations, mostly affecting the toes, in patients treated with the diabetes medicine canagliflozin, according...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news